SPY415.87+4.42 1.07%
DIA340.44+2.91 0.86%
IXIC14,038.76+180.92 1.31%

Summit Therapeutics Q4 EPS $(0.18) Up From $(0.34) YoY

Summit Therapeutics (NASDAQ:SMMT) reported quarterly losses of $(0.18) per share. This is a 47.06 percent increase over losses of $(0.34) per share from the same period last year.

· 03/17/2021 07:11
Summit Therapeutics (NASDAQ:SMMT) reported quarterly losses of $(0.18) per share. This is a 47.06 percent increase over losses of $(0.34) per share from the same period last year.